Publication | Closed Access

Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder

PsychiatryPsychotic DisorderPatient SafetyPsychopharmacologySchizophreniaSocial SciencesClinical PsychiatryMedicineDouble-blind ComparisonStable OutpatientsSchizoaffective DisorderPsychopathology